BRIDGEBIO PHARMA INC
BBIONASDAQ🏆 #745 by market capEarnings Oct 28US Equity
$65.97▼ $0.63 (−0.96%)
🌙 After hours$66.00▲ 0.05%Regular close · extended-hours price shownTrack BBIO
Get earnings, price moves & breaking news on Telegram
24h▼ 1.0%
7d▼ 4.7%
14d▼ 3.6%
30d▼ 13.9%
ytd▼ 13.8%
1y▲ 27.0%
🏦Market Cap
$12.92B
Mid Cap
📈Revenue Growth (YoY)
+126.3%
High Growth
📊Gross Margin
93.1%
High
💵FCF Margin
-85.6%
Thin
⚖️P/S Ratio
18.7x
Expensive
Otter Score
64
Fair
Earnings
Q3 · 2026Reported 2026-08-10Earnings Per Share
Actual
-0.78
Expected
-0.58
miss
−35.50%
YoY +17.90%
Revenue
Actual
$243.68M
Expected
$220.91M
beat
+10.30%
YoY +120.40%
Consensus estimates
Recent quarters
Q3 2026
-0.78
miss
Q2 2026
-0.84
miss
Q1 2026
-1.00
miss
Q4 2025
-0.95
miss